Description

Spiro[Furo[3,4-C]Pyridine-3(1H),4'-Piperidine] CAS NO 1017599-04-0 is a high-purity, advanced pharmaceutical intermediate featuring a complex spirocyclic and fused heterocyclic structure. This compound is of significant value for medicinal chemistry research and development, serving as a critical building block for novel active pharmaceutical ingredients (APIs). It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in the synthesis of new therapeutic agents targeting the central nervous system and other disease areas.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates, particularly in central nervous system (CNS) and psychiatric disorder research.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies to optimize potency, selectivity, and pharmacokinetic properties of lead compounds.
• Library Synthesis: Employed in the generation of diverse compound libraries for high-throughput screening (HTS) against various biological targets.
• Process Chemistry Development: Serves as a critical intermediate during the scale-up and optimization of API manufacturing processes under GMP conditions.
• Academic Research: Utilized in university and institutional labs for fundamental studies in organic synthesis and heterocyclic chemistry.

Basic Information

Product Name	Spiro[Furo[3,4-C]Pyridine-3(1H),4'-Piperidine]
CAS No.	1017599-04-0
Molecular Formula	C11H12N2O
Molecular Weight	188.23 g/mol
Synonyms	1'H-Spiro[furo[3,4-c]pyridine-3,4'-piperidine]; Spiro(furo[3,4-c]pyridine-3(1H),4'-piperidine); 1'H-Spiro(furo[3,4-c]pyridine-3,4'-piperidine); Furo[3,4-c]pyridine-3(1H),4'-piperidine, spiro-; 1017599-04-0; Spiro[furo[3,4-c]pyridine-3(1H),4'-piperidine]; Spiro(furo[3,4-c]pyridine-3,4'-piperidine)
EINECS	Contact for details

Quality Control

Our Spiro[Furo[3,4-C]Pyridine-3(1H),4'-Piperidine] is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) with detailed chromatographic data are provided for every shipment. We support development and commercial projects with material suitable for research use and can supply grades aligned with cGMP standards for advanced clinical trials.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept tightly sealed in a dry environment and handled under conditions that minimize exposure to ambient light and humidity to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.